Top Markets
Coin of the day
TheraVet S.A. TheraVet S.A.

TheraVet S.A.

ALVET
Rank in Stocks #40004
TheraVet S.A. operates as a veterinary biotechnology firm, delivering... TheraVet S.A. operates as a veterinary biotechnology firm, delivering specialized osteoarticular therapies for animals across Belgium, France, Switzerland, the United Kingdom, and the United States. The company's primary focus is on providing solutions for osteoarthritis, ligament and tendon damage, and bone surgery requirements in felines, canines, and equines. Its product lineup includes BIOCERA-VET, formulated to enhance bone integration and remodeling, and VISCO-VET. The latter is an injectable, hyaluronic acid-based gel that facilitates regeneration, exhibits anti-inflammatory characteristics, boosts the effectiveness of active compounds, and promotes cellular colonization essential for tissue repair. Founded in 2017, TheraVet S.A. has its corporate base situated in Jumet, Belgium.
Share Price
$0.08585084
Last synced: 2025-02-24
Market Cap
$276.78K
Change (1 day)
0.05%
Change (1 year)
0.00%
Country
BE
Trade TheraVet S.A. (ALVET)

Category

Dividend yield history for TheraVet S.A. (ALVET)
TheraVet S.A. (stock symbol: ALVET) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for TheraVet S.A. (ALVET) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors